Natural Capsules Ltd

Natural Capsules Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Natural Capsules Ltd

₹ 254 1.18%
06 Jun 10:14 a.m.
naturalcapsules.com BSE: 524654 NSE: NATCAPSUQ
About

Incorporated in 1993, Natural Capsules manufactures Capsules and Steroidal APIs and their Intermediates and Derivatives[1]

Key Points

Business Overview:[1][2][3]
NCL is a WHO-GMP certified and ISO 9001, ISO 140001 compliance manufacturer of printed and unprinted hard two-piece Gelatin and Cellulose (HPMC : non-animal alternative) capsules for pharmaceutical and dietary supplement industries in various sizes of 00, 0el, 0, 1, 2, 3 & 4. Apart from this, NCL has forayed into API manufacturing with complex high-end patented technology developed in-house, under its subsidiary company Natural Biogenex Private Limited.

Website BSE NSE
  • Market Cap ₹ 262 Cr.
  • Current Price ₹ 254
  • High / Low ₹ 377 / 164
  • Stock P/E 39.1
  • Book Value ₹ 161
  • Dividend Yield 0.00 %
  • ROCE 7.30 %
  • ROE 4.50 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 8.85% over last 3 years.
  • Dividend payout has been low at 1.61% of profits over last 3 years
  • Promoter holding has decreased over last 3 years: -5.36%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
41.55 44.19 45.06 45.50 38.12 37.70 37.52 38.38 40.20 39.14 41.03 43.41 44.36
33.37 35.01 35.40 35.80 31.23 31.64 32.28 33.44 35.70 34.41 36.09 38.82 39.32
Operating Profit 8.18 9.18 9.66 9.70 6.89 6.06 5.24 4.94 4.50 4.73 4.94 4.59 5.04
OPM % 19.69% 20.77% 21.44% 21.32% 18.07% 16.07% 13.97% 12.87% 11.19% 12.08% 12.04% 10.57% 11.36%
0.73 0.21 0.04 0.01 0.81 0.58 0.61 0.71 1.26 0.76 0.77 1.15 1.55
Interest 0.67 0.62 0.72 0.95 1.27 1.21 1.15 1.20 1.38 1.46 1.54 1.39 1.52
Depreciation 1.39 1.63 1.95 1.74 1.86 2.11 2.16 2.16 2.14 2.09 2.16 2.14 1.94
Profit before tax 6.85 7.14 7.03 7.02 4.57 3.32 2.54 2.29 2.24 1.94 2.01 2.21 3.13
Tax % 25.69% 26.61% 24.04% 25.21% 26.26% 25.90% 22.44% 25.76% 24.55% 24.74% 54.23% 23.08% 16.29%
5.09 5.24 5.34 5.25 3.37 2.46 1.97 1.70 1.69 1.46 0.92 1.70 2.63
EPS in Rs 5.47 5.63 5.74 5.65 3.66 2.65 2.12 1.82 1.81 1.56 0.90 1.64 2.54
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
59 67 62 54 55 60 62 80 135 171 153 168
47 56 52 49 49 55 56 68 109 135 133 149
Operating Profit 11 12 10 5 6 5 5 11 26 36 21 19
OPM % 19% 17% 16% 10% 10% 8% 9% 14% 19% 21% 14% 11%
1 1 1 0 1 1 1 3 1 1 3 4
Interest 1 1 1 1 0 1 1 1 2 4 5 6
Depreciation 4 4 4 4 4 3 4 4 5 7 9 8
Profit before tax 7 8 6 0 2 2 1 9 19 26 10 9
Tax % 39% 25% 28% -103% 34% 7% 38% 24% 28% 25% 25% 28%
5 6 4 1 1 2 1 7 14 19 8 7
EPS in Rs 6.08 7.15 4.99 0.68 1.19 2.06 0.92 7.47 15.00 20.83 8.38 6.49
Dividend Payout % 17% 14% 20% 99% 56% 32% 43% 9% 5% 5% 0% 0%
Compounded Sales Growth
10 Years: 10%
5 Years: 22%
3 Years: 8%
TTM: 9%
Compounded Profit Growth
10 Years: 2%
5 Years: 51%
3 Years: -22%
TTM: -14%
Stock Price CAGR
10 Years: 16%
5 Years: 45%
3 Years: -17%
1 Year: -11%
Return on Equity
10 Years: 8%
5 Years: 10%
3 Years: 9%
Last Year: 5%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 5 5 6 6 6 6 6 6 7 9 9 10
Reserves 38 42 50 48 48 49 49 56 76 115 123 156
6 5 6 3 0 5 6 10 33 49 62 56
11 11 16 14 19 14 14 26 28 38 37 45
Total Liabilities 59 63 77 71 73 75 76 98 144 211 231 268
31 29 30 26 22 24 24 35 63 93 91 88
CWIP 2 2 0 0 1 2 2 3 1 0 2 0
Investments 0 0 5 5 5 5 6 0 0 20 23 23
26 32 42 40 45 43 45 60 80 98 116 157
Total Assets 59 63 77 71 73 75 76 98 144 211 231 268

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
7 5 3 2 5 2 7 6 5 20 5 18
-4 -4 -8 -0 -1 -7 -6 -9 -30 -55 -11 -34
-3 -1 4 -2 -4 4 -1 3 27 34 7 15
Net Cash Flow 0 -0 0 0 0 -1 0 -0 1 -1 2 -2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 118 125 167 191 208 197 180 123 71 111 127 133
Inventory Days 53 66 147 119 149 87 89 82 34 43 83 92
Days Payable 70 74 148 159 185 114 91 157 97 127 140 155
Cash Conversion Cycle 101 117 166 151 172 170 179 48 7 28 70 70
Working Capital Days 104 116 155 175 186 169 158 160 81 84 114 117
ROCE % 18% 17% 12% 3% 4% 5% 4% 11% 23% 20% 8% 7%

Shareholding Pattern

Numbers in percentages

7 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
56.57% 56.57% 56.57% 56.57% 56.57% 56.57% 56.57% 56.57% 56.57% 51.59% 51.13% 51.21%
1.22% 1.22% 1.31% 1.31% 1.31% 1.31% 1.31% 1.31% 0.18% 0.00% 0.00% 0.00%
42.21% 42.23% 42.12% 42.13% 42.13% 42.13% 42.13% 42.13% 43.25% 48.39% 48.86% 48.80%
No. of Shareholders 7,1417,8778,2358,66610,80511,67511,39910,95410,5149,8629,6619,425

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls